MDS Pharma Services
Global contract research organization providing integrated drug discovery, preclinical and clinical development services, including discovery and preclinical testing, early clinical research (Phase I/IIa), global clinical development (Phase II-IV), central laboratory testing and specimen logistics, bioanalysis, development and regulatory support, and quality assurance. Operates an international network of harmonized laboratories and clinical facilities supported by integrated information systems and program-level project management.
Industries
Nr. of Employees
Very Large (1000+)
Products
Web-based central lab protocol management and reporting system
A web-based system for monitoring central lab activities including kit design, specimen tracking, instrument processing and reporting across global facilities.
Cartouch Device
A digital 12-lead ECG device developed by MDS Pharma Services for clinical studies, suitable for Phase I/IIa and Phase IIb-IV studies, enabling consistent ECG data collection throughout drug development.
Cardiac Safety Center of Excellence
MDS Pharma Services offers comprehensive cardiac safety services including high-quality ECG data production, strategic consultation, study design, data management, and regulatory submission support for clinical trials.
MDS Pharma Services Phoenix Clinical Research Facility
A state-of-the-art clinical research facility in Phoenix, Arizona, offering comprehensive capabilities including a full clinical laboratory with the largest early phase clinical-bed capacity in the Western U.S. Expanded to 420 beds to meet increasing demand for clinical trials.
GE MAC® 1200
A widely used ECG device in clinical studies offering easy, immediate printing of ECG traces with automated interpretation, built-in keyboard for data entry, and a large display screen for viewing ECG traces during acquisition.
ELA Medical Spiderview™
A digital multiple-lead Holter recorder selected by MDS Pharma Services for 2 to 12-lead Holter monitoring, compact and easy to use with a wide LCD display screen, capable of continuous recording for up to 96 hours in uncompressed and high resolution data modes.
Web-based central lab protocol management and reporting system
A web-based system for monitoring central lab activities including kit design, specimen tracking, instrument processing and reporting across global facilities.
Cartouch Device
A digital 12-lead ECG device developed by MDS Pharma Services for clinical studies, suitable for Phase I/IIa and Phase IIb-IV studies, enabling consistent ECG data collection throughout drug development.
Cardiac Safety Center of Excellence
MDS Pharma Services offers comprehensive cardiac safety services including high-quality ECG data production, strategic consultation, study design, data management, and regulatory submission support for clinical trials.
MDS Pharma Services Phoenix Clinical Research Facility
A state-of-the-art clinical research facility in Phoenix, Arizona, offering comprehensive capabilities including a full clinical laboratory with the largest early phase clinical-bed capacity in the Western U.S. Expanded to 420 beds to meet increasing demand for clinical trials.
GE MAC® 1200
A widely used ECG device in clinical studies offering easy, immediate printing of ECG traces with automated interpretation, built-in keyboard for data entry, and a large display screen for viewing ECG traces during acquisition.
ELA Medical Spiderview™
A digital multiple-lead Holter recorder selected by MDS Pharma Services for 2 to 12-lead Holter monitoring, compact and easy to use with a wide LCD display screen, capable of continuous recording for up to 96 hours in uncompressed and high resolution data modes.
Services
End-to-end clinical development support including feasibility, site selection, project management, monitoring, medical affairs, data management and biostatistics for multi-region trials.
Clinical pharmacology and Phase I/IIa study conduct with clinical pharmacology units, inpatient facilities and PK/PD support.
Harmonized, CAP-certified lab network offering standardized assays, specimen management, kit production/distribution and global logistics.
Bioanalytical method development, validated assays and routine testing using LC-MS/MS and ligand binding technologies to meet regulatory standards.
Scientific and regulatory consulting including drug and biopharmaceutical development, regulatory affairs and program management to support submissions and program strategies.
Global QA organization supporting a Quality Management System, QA oversight across lines of business and computer validation to ensure compliance.
End-to-end clinical development support including feasibility, site selection, project management, monitoring, medical affairs, data management and biostatistics for multi-region trials.
Clinical pharmacology and Phase I/IIa study conduct with clinical pharmacology units, inpatient facilities and PK/PD support.
Harmonized, CAP-certified lab network offering standardized assays, specimen management, kit production/distribution and global logistics.
Bioanalytical method development, validated assays and routine testing using LC-MS/MS and ligand binding technologies to meet regulatory standards.
Scientific and regulatory consulting including drug and biopharmaceutical development, regulatory affairs and program management to support submissions and program strategies.
Global QA organization supporting a Quality Management System, QA oversight across lines of business and computer validation to ensure compliance.
Expertise Areas
- Clinical trial management (Phase II-IV)
- Early clinical research and clinical pharmacology (Phase I-IIa)
- Central laboratory testing and specimen logistics
- Bioanalysis for small and large molecules
Key Technologies
- Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
- Ligand binding assays (immunoassays)
- Electronic data capture (EDC) and clinical data management
- Web-based central lab management and reporting systems
News & Updates
Announcement of appointment of a laboratory director for the Beijing central laboratory.
Company scientist recognized in an industry list of notable R&D professionals for 2009.
Company scientist scheduled to discuss development of biosimilar monoclonal antibodies at an industry symposium.
Ranked among the Top 5 CROs by CenterWatch surveys across multiple attributes from 2001 to 2008.
Recognized as Top CRO in Europe and Most Promising CRO in Asia Pacific (2006) by industry surveys and analysts.
Recipient of a GCPj award in 2007 for a public-private collaboration on a global malaria project.
Announcement of appointment of a laboratory director for the Beijing central laboratory.
Company scientist recognized in an industry list of notable R&D professionals for 2009.
Company scientist scheduled to discuss development of biosimilar monoclonal antibodies at an industry symposium.
Ranked among the Top 5 CROs by CenterWatch surveys across multiple attributes from 2001 to 2008.
Recognized as Top CRO in Europe and Most Promising CRO in Asia Pacific (2006) by industry surveys and analysts.
Recipient of a GCPj award in 2007 for a public-private collaboration on a global malaria project.